These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31616949)

  • 21. Comparison of IgM capture ELISA with a commercial rapid immunochromatographic card test & IgM microwell ELISA for the detection of antibodies to dengue viruses.
    Sathish N; Manayani DJ; Shankar V; Abraham M; Nithyanandam G; Sridharan G
    Indian J Med Res; 2002 Feb; 115():31-6. PubMed ID: 12138661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of the performances of six commercial kits designed for dengue NS1 and anti-dengue IgM, IgG and IgA detection in urine and saliva clinical specimens.
    Andries AC; Duong V; Ong S; Ros S; Sakuntabhai A; Horwood P; Dussart P; Buchy P
    BMC Infect Dis; 2016 May; 16():201. PubMed ID: 27184801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serological evidence of Flavivirus circulation in human populations in Northern Kenya: an assessment of disease risk 2016-2017.
    Chepkorir E; Tchouassi DP; Konongoi SL; Lutomiah J; Tigoi C; Irura Z; Eyase F; Venter M; Sang R
    Virol J; 2019 May; 16(1):65. PubMed ID: 31101058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of the immunoglobulin G avidity assay to differentiate between recent Zika and past dengue virus infections.
    Furuya AKM; Hunt D; George KS; Dupuis AP; Kramer LD; Shi PY; Wong S
    Clin Sci (Lond); 2019 Apr; 133(7):859-867. PubMed ID: 30902827
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of recombinant dengue viral envelope B domain protein antigens for the detection of dengue complex-specific antibodies.
    Simmons M; Porter KR; Escamilla J; Graham R; Watts DM; Eckels KH; Hayes CG
    Am J Trop Med Hyg; 1998 Feb; 58(2):144-51. PubMed ID: 9502595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accuracy of the SD BIOLINE Dengue Duo for rapid point-of-care diagnosis of dengue.
    Kikuti M; Cruz JS; Rodrigues MS; Tavares AS; Paploski IAD; Silva MMO; Santana PM; Tauro LB; Silva GAOF; Campos GS; Araújo JMG; Kitron U; Reis MG; Ribeiro GS
    PLoS One; 2019; 14(3):e0213301. PubMed ID: 30840708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of dengue NS1 antigen rapid tests and ELISA kits using clinical samples.
    Pal S; Dauner AL; Mitra I; Forshey BM; Garcia P; Morrison AC; Halsey ES; Kochel TJ; Wu SJ
    PLoS One; 2014; 9(11):e113411. PubMed ID: 25412170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of dengue and COVID-19 antibody rapid diagnostic tests cross-reactivity in Indonesia.
    Santoso MS; Masyeni S; Haryanto S; Yohan B; Hibberd ML; Sasmono RT
    Virol J; 2021 Mar; 18(1):54. PubMed ID: 33706767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of cross-reactivity between flaviviruses with sera of patients with Japanese encephalitis showed the importance of neutralization tests for the diagnosis of Japanese encephalitis.
    Maeki T; Tajima S; Ikeda M; Kato F; Taniguchi S; Nakayama E; Takasaki T; Lim CK; Saijo M
    J Infect Chemother; 2019 Oct; 25(10):786-790. PubMed ID: 31105002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancing the concordance of two commercial dengue IgG ELISAs by exchange of the calibrator sample.
    Schüttoff T; Adam A; Reiche S; Jassoy C
    J Clin Virol; 2019 Sep; 118():1-5. PubMed ID: 31301516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Six Commercial Diagnostic Tests for the Detection of Dengue Virus Non-Structural-1 Antigen and IgM/IgG Antibodies.
    Lee H; Ryu JH; Park HS; Park KH; Bae H; Yun S; Choi AR; Cho SY; Park C; Lee DG; Lim J; Lee J; Lee S; Shin S; Park H; Oh EJ
    Ann Lab Med; 2019 Nov; 39(6):566-571. PubMed ID: 31240885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determining dengue virus serostatus by indirect IgG ELISA compared with focus reduction neutralisation test in children in Cebu, Philippines: a prospective population-based study.
    Lopez AL; Adams C; Ylade M; Jadi R; Daag JV; Molloy CT; Agrupis KA; Kim DR; Silva MW; Yoon IK; White L; Deen J; de Silva AM
    Lancet Glob Health; 2021 Jan; 9(1):e44-e51. PubMed ID: 33212030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of immunoglobulin M-specific capture enzyme-linked immunosorbent assays and commercial tests for flaviviruses diagnosis by a National Reference Laboratory.
    Henriques DF; Nunes JAL; Anjos MV; Melo JM; Rosário WO; Azevedo RSS; Chiang JO; Martins LC; Dos Santos FB; Casseb LMN; Vasconcelos PFC; Rodrigues SG
    J Virol Methods; 2020 Dec; 286():113976. PubMed ID: 32971183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Accuracy and efficacy of pre-dengue vaccination screening for previous dengue infection with a new dengue rapid diagnostic test: a retrospective analysis of phase 3 efficacy trials.
    Savarino SJ; Bonaparte M; Wang H; Dayan GH; Forrat R; Zhu M; Hodge S; Ataman-Önal Y; DiazGranados CA
    Lancet Microbe; 2022 Jun; 3(6):e427-e434. PubMed ID: 35659904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity and safety of a tetravalent dengue vaccine in healthy adults in India: A randomized, observer-blind, placebo-controlled phase II trial.
    Dubey AP; Agarkhedkar S; Chhatwal J; Narayan A; Ganguly S; Wartel TA; Bouckenooghe A; Menezes J
    Hum Vaccin Immunother; 2016; 12(2):512-8. PubMed ID: 26291554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Dengue Vaccination on Serological Diagnosis: Insights From Phase III Dengue Vaccine Efficacy Trials.
    Plennevaux E; Moureau A; Arredondo-García JL; Villar L; Pitisuttithum P; Tran NH; Bonaparte M; Chansinghakul D; Coronel DL; L'Azou M; Ochiai RL; Toh ML; Noriega F; Bouckenooghe A
    Clin Infect Dis; 2018 Apr; 66(8):1164-1172. PubMed ID: 29300876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonstructural protein 1-specific immunoglobulin M and G antibody capture enzyme-linked immunosorbent assays in diagnosis of flaviviral infections in humans.
    Chao DY; Galula JU; Shen WF; Davis BS; Chang GJ
    J Clin Microbiol; 2015 Feb; 53(2):557-66. PubMed ID: 25502522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessment of diagnostic and analytic performance of the SD Bioline Dengue Duo test for dengue virus (DENV) infections in an endemic area (Savannakhet province, Lao People's Democratic Republic).
    Blessmann J; Winkelmann Y; Keoviengkhone L; Sopraseuth V; Kann S; Hansen J; El Halas H; Emmerich P; Schmidt-Chanasit J; Schmitz H; Mika A; Deschermeier C
    PLoS One; 2020; 15(3):e0230337. PubMed ID: 32182271
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive Evaluation of Differential Serodiagnosis between Zika and Dengue Viral Infections.
    Chao DY; Whitney MT; Davis BS; Medina FA; Munoz JL; Chang GJ
    J Clin Microbiol; 2019 Mar; 57(3):. PubMed ID: 30541932
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of a dengue IgG indirect enzyme-linked immunosorbent assay and a Japanese encephalitis IgG indirect enzyme-linked immunosorbent assay for diagnosis of secondary dengue virus infection.
    Inoue S; Alonzo MT; Kurosawa Y; Mapua CA; Reyes JD; Dimaano EM; Alera MT; Saito M; Oishi K; Hasebe F; Matias RR; Natividad FF; Morita K
    Vector Borne Zoonotic Dis; 2010 Mar; 10(2):143-50. PubMed ID: 19874185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.